Literature DB >> 2437306

Synthesis of new heparinoids with high anticoagulant activity.

K Hatanaka, T Yoshida, S Miyahara, T Sato, F Ono, T Uryu, H Kuzuhara.   

Abstract

New heparinoids were synthesized by the chemical method starting from ring-opening polymerization of anhydro sugar derivatives. Sulfation of synthetic (1----6)-alpha-linked 3-amino-3-deoxy-D-glucopyranan and its copolymers gave dextran-type heparinoids having a sulfamide group on the C-3 carbon of the sugar unit. Heparinoids with different sulfamide contents indicated that the anticoagulant activity (35.3-41.3 units/mg) is independent of the sulfamide content, while an increase in sulfamide content lowered the toxicity. Sulfation of (1----5)-alpha-D-xylofuranan and -ribofuranan provided furanan-type heparinoids the anticoagulant activities of which were higher than those of the corresponding sulfated pyranan-type polysaccharides (1----4)-beta-D-xylopyranan and -ribopyranan. The highest activity (69.1 units/mg) was shown by sulfated (1----5)-alpha-D-xylofuranan. The dextran-type heparinoid having a sulfamide group showed a high anticoagulant activity also in vivo and high lipemia-clearing activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437306     DOI: 10.1021/jm00388a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Neuroactive chondroitin sulfate glycomimetics.

Authors:  Manish Rawat; Cristal I Gama; John B Matson; Linda C Hsieh-Wilson
Journal:  J Am Chem Soc       Date:  2008-02-15       Impact factor: 15.419

2.  Synthesis and anticoagulant activity of polyureas containing sulfated carbohydrates.

Authors:  Yongshun Huang; Maureen A Shaw; Eric S Mullins; Terence L Kirley; Neil Ayres
Journal:  Biomacromolecules       Date:  2014-11-05       Impact factor: 6.988

3.  Synthesis of an inhibitor of human immunodeficiency virus infection.

Authors:  K Hatanaka; T Yoshida; T Uryu; O Yoshida; H Nakashima; N Yamamoto; T Mimura; Y Kaneko
Journal:  Jpn J Cancer Res       Date:  1989-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.